Litigation Details for Insys Therapeutics, Inc. v. Alkem Laboratories Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Insys Therapeutics, Inc. v. Alkem Laboratories Ltd. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-10-10 |
Court | District Court, D. Delaware | Date Terminated | 2018-07-13 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | Defendant | Referred To | |
Patents | 8,222,292; 9,345,771 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Insys Therapeutics, Inc. v. Alkem Laboratories Ltd.
Details for Insys Therapeutics, Inc. v. Alkem Laboratories Ltd. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-10-10 | 1 | United States Patent Nos. 8,222,292 (“the ’292 patent”) and 9,345,771 (“the ’771 patent”); (collectively…collectively, “the patents-in-suit”). This action arises under the Patent Laws of the United States, 35 U.S.… the ’292 patent is attached as Exhibit A. 18. Insys Dev owns the ’292 patent. 19… the ’771 patent is attached as Exhibit B. 20. Insys Dev owns the ’771 patent. 21…claims of the patents-in-suit. Alkem’s Infringement of the Patents-In-Suit | External link to document | |
2017-10-10 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,222,292 B2; 9,345,771 B2. (…2017 13 July 2018 1:17-cv-01419 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
2018-07-23 | 41 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Numbers 8,222,292 B2 ;9,345,771 B2. (etg…2017 13 July 2018 1:17-cv-01419 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |